Companies by HQ LocationTech Companies and Startups Headquartered in South San Francisco
80 companies in this collection.
List of companies headquartered in South San Francisco
Select...
Loading...
Page 1 of NaN
Displaying companies
Reprompt is the control panel for production AI systems. | South San Francisco | CA | 1 - 10 | 2024 | $1,000,000 |
Shinobi Therapeutics focuses on creating hypoimmune CD8αβ iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therap | South San Francisco | CA | 10 - 50 | 2023 | $178,000,000 |
Velorum Therapeutics produces powerful cancer treatments that starve tumors. | South San Francisco | CA | 1 - 10 | 2023 | $500,000 |
NewLimit specializes in treating age-related diseases to extend the human health span. It works on developing epigenetic reprogramming medicines to treat diseases with large unmet needs. | South San Francisco | CA | 5 - 20 | 2022 | $40,000,000 |
Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | South San Francisco | CA | 20 - 50 | 2022 | $54,000,000 |
Resilient, modular, reconfigurable, no-integration-code automated material flow and storage system enabled by robotics and AI | South San Francisco | CA | 20 - 100 | 2022 | $78,000,000 |
Midjourney is an artificial intelligence-powered artwork generator. It explores new thought mediums and expands the human species' imaginative powers. It is a small self-funded team focused on design, human infrastructure, and artificial intelligence. | South San Francisco | CA | 50 - 200 | 2022 | |
Wispr AI is a developer of the next-generation of neural interfaces to provide seamless interface with immersive technology. The company is working with the leading neuroscientist, hardware engineers, machine learning researchers, and product engineers to | South San Francisco | CA | 20 - 50 | 2021 | $14,600,000 |
Esker is a precision medicines company looking to eliminate the “all-comers” approach that is seen with today’s treatments for people with autoimmune disease. Even with the innovation of the last decade, many patients continue to cycle through the approved | South San Francisco | CA | 50 - 200 | 2021 | $529,000,000 |
coinroll is a secure and compliant fintech platform designed for institutional investors which facilitates effortless-full-cycle digital investments and provides up-to-date insights on emerging investment opportunities. coinroll achieves this with intense | South San Francisco | CA | 5 - 10 | 2021 | $1,264,000 |
Deep Origin is a biotechnology company that offers a platform for life sciences R&D. | South San Francisco | CA | 10 - 50 | 2021 | $29,406,104 |
Seranova Bio partners with clinicians and drug developers to develop companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases. The company's REAP platform was developed to detect autoantibodies that recognize | South San Francisco | CA | 5 - 20 | 2020 | $15,049,985 |
FORMA is an incubator, accelerator, and curator of next-generation beauty brands launching as a multi-category platform. The company celebrates, supports, and seeks those changing the world through creative expression. Each brand in its portfolio is though | South San Francisco | CA | 100 - 500 | 2020 | |
Graphite Bio is a next-generation gene editing company focused on the development of first-in-class therapies for patients suffering from life-threatening genetic diseases. The company’s platform harnesses the natural cellular process of homology directed | South San Francisco | CA | 100 - 500 | 2020 | $195,749,984 |
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities. It uses genomics, proteomics, structural biology, and computational chemistry to map and modulate protein communities. Interl | South San Francisco | CA | 20 - 100 | 2020 | $92,000,000 |
Sonoma Biotherapeutics is a company invloved the development of adoptive Treg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class | South San Francisco | CA | 100 - 500 | 2020 | $365,000,000 |
Driverless electric vehicles at a fraction of the cost of a car. | South San Francisco | CA | 10 - 50 | 2020 | $11,900,000 |
Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. | South San Francisco | CA | 20 - 50 | 2020 | $42,000,000 |
Swiftscale Biologics uses cell-free protein synthesis to enable the next generation of protein therapeutics. | South San Francisco | CA | 10 - 20 | 2019 | $15,000,000 |
ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases, initially cancer. | South San Francisco | CA | 100 - 500 | 2019 | $630,806,656 |
Cellares is revolutionizing cell therapy manufacturing. Cellares is developing a one-of-a-kind solution, The Cell Shuttle, to overcome the challenges associated with manufacturing so these life-saving therapies are affordable and widely available to patien | South San Francisco | CA | 100 - 500 | 2019 | $355,000,000 |
Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. | South San Francisco | CA | 20 - 100 | 2019 | $50,000,000 |
Mirvie is redefining pregnancy health by developing the first early detection RNA test to address pregnancy complications which impact 45 million women globally. | South San Francisco | CA | 20 - 50 | 2019 | $70,400,000 |
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform. | South San Francisco | CA | 20 - 50 | 2019 | $226,600,000 |
Asher Bio is an information technology company that specializes in the fields of CFO Office transformation, profitability, and cost management. It focuses on building and developing better immunotherapy for cancer. The company was founded in 2019 and headq | South San Francisco | CA | 20 - 100 | 2019 | $218,150,000 |
Epic Bio's strength is a relentless focus on ushering in a new era of gene regulation. | South San Francisco | CA | 20 - 50 | 2018 | $55,000,000 |
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therapeutics for cancer and inflammatory diseases. | South San Francisco | CA | 20 - 100 | 2018 | $85,000,000 |
Earli Inc. operates as a biotechnology company. The Company develops treatments to cure cancer. Earli serves patients in the State of California. | South San Francisco | CA | 20 - 100 | 2018 | $59,900,000 |
Translating genetic insights into therapeutic innovations · Harnessing the potential of modern human genetics to treat disease. | South San Francisco | CA | 100 - 500 | 2018 | $381,000,000 |
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral t | South San Francisco | CA | 83 - 500 | 2018 | $317,000,000 |
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. | South San Francisco | CA | 20 - 100 | 2018 | $213,500,000 |
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients. | South San Francisco | CA | 20 - 50 | 2018 | $190,000,000 |
Frontier Medicines’is a developer of a chemoproteomics platform intended to further accelerate the path to drug discovery. The company's platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new | South San Francisco | CA | 100 - 500 | 2018 | $344,000,000 |
Insitro is an operator of a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company uses state-of-the-art technologi | South San Francisco | CA | 200 - 500 | 2018 | $643,000,000 |
Presidio Medical is a medtech company that develops a transformational neuromodulation platform. It enables people to receive remedies for disorders affecting neuronal activity. | South San Francisco | CA | 20 - 100 | 2017 | $102,000,000 |
Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California. | South San Francisco | CA | 200 - 500 | 2017 | $1,011,770,368 |
InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM signals found in human blood and tissue for biomarker and target discovery. It specializes in the fields of biotechnology and life science. The comp | South San Francisco | CA | 100 - 500 | 2017 | $244,400,000 |
Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammat | South San Francisco | CA | 10 - 50 | 2016 | $65,350,000 |
Surrozen Inc produces and distributes pharmaceutical products. The Company develops pathway that drive tissue regeneration addressing a variety of critical unmet medical needs. Surrozen operates in the United States. | South San Francisco | CA | 20 - 100 | 2016 | $270,500,000 |
Glydways is a transportation technology and clean energy company that designs and manufactures autonomous transportation. | South San Francisco | CA | 20 - 100 | 2016 | $111,230,800 |
We make delicious cheese from plant-derived dairy proteins, supporting a larger mission of creating a radically more humane and sustainable food system. Our cheese stretches, melts, and tastes as great as the ones from cows and goats-minus the animals. | South San Francisco | CA | 20 - 100 | 2016 | $75,000,000 |
Genome Medical, Inc. operates as a national telegenomics technology and services company. The Company provides virtual genetic care and services for individuals, health systems, providers and employers to improve health and well- being. Genome Medical, Inc | South San Francisco | CA | 100 - 200 | 2016 | $120,400,000 |
Tenaya Therapeutics, Inc. operates as a biotechnology company. The Company focuses on discovering and developing novel therapies for heart failure. | South San Francisco | CA | 100 - 500 | 2016 | $373,000,000 |
Beehive AI develops analytical tools intended to device business strategies and actions. Its tools help optimize ad messaging and targeting, enabling clients to understand which product or services add the most value. | South San Francisco | CA | 10 - 50 | 2016 | $5,100,000 |
IDEAYA Biosciences, Inc. operates as an oncology-focused biotechnology company. The Company develops biology and small molecule based drugs and therapeutics for the treatment of cancer. IDEAYA Biosciences serves healthcare sectors in the United States. | South San Francisco | CA | 100 - 500 | 2015 | $431,100,000 |
Denali Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops medicines for neurodegenerative diseases. Denali Therapeutics serves patients in the State of California. | South San Francisco | CA | 100 - 500 | 2015 | $133,500,000 |
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered protein | South San Francisco | CA | 50 - 500 | 2015 | $255,000,000 |
Blade Therapeutics, Inc. operates as a biopharmaceutical company for treating fibrosis. The Company offers screening, drug discovery and development, tissue replacement, and fibrotic disease management. Blade Therapeutics conducts its business in the Unite | South San Francisco | CA | 20 - 50 | 2015 | $51,500,000 |
Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases. | South San Francisco | CA | 20 - 100 | 2015 | $134,120,000 |
Verily Life Sciences, also known as Verily (formerly Google Life Sciences), is Alphabet Inc.'s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until August 10, 2015, when Sergey Brin announ | South San Francisco | CA | 2,000 - 5,000 | 2015 | $3,500,000,000 |
Cafe X Technologies is focused on increasing productivity in the service industry through automation. Cafe X Technologies is a privately backed company with funding from Khosla Ventures, Social Capital, Jason Calacanis, Felicis Ventures, Silicon Valley Ban | South San Francisco | CA | 10 - 50 | 2015 | $14,520,709 |
Enable Biosciences is a South San Francisco-based diagnostics company. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases. | South San Francisco | CA | 10 - 50 | 2015 | $4,157,163 |
Escape Bio, Inc. operates as a preclinical stage biopharmaceutical company. The Company discovers and develops small molecule drugs and medicines to treat genetically-defined subpopulations in neurodegenerative diseases. Escape Bio serves customers in the | South San Francisco | CA | 20 - 50 | 2015 | $187,076,080 |
Nkarta, Inc. operates as a biotech company. The Company develops and discovers therapies for immune systems and cancer indications. Nkarta serves patients in the State of California. | South San Francisco | CA | 100 - 200 | 2015 | $595,000,000 |
Applied Molecular Transport Inc. operates as a biotech company. The Company develops novel therapeutics to treat severe autoimmune, metabolic, and inflammatory diseases. Applied Molecular Transport serves customers in the State of California. | South San Francisco | CA | 79 - 500 | 2015 | $193,700,000 |
Tizona Therapeutics, Inc., is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. | South San Francisco | CA | 20 - 50 | 2015 | $370,000,000 |
Zenflow, Inc. operates as a medical device company. The Company develops minimally invasive devices to treat obstructive urinary symptoms related to benign prostatic hyperplasia. Zenflow serves customers in the State of California. | South San Francisco | CA | 10 - 50 | 2014 | $56,068,844 |
Plenty, Inc. produces food crops. The Company offers natural agricultural crops and products. Plenty serves customers in the State of California. | South San Francisco | CA | 200 - 500 | 2014 | $941,000,000 |
The EVERY Company, headquartered in South San Francisco, is a market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Originally founded as Clara Foods in 2014, EVER | South San Francisco | CA | 100 - 500 | 2014 | $239,750,000 |
Mission Bio, Inc. develops and delivers tools for the study of cellular heterogeneity. The Company offers tools for human health and life science research. Mission Bio serves customers in the State of California. | South San Francisco | CA | 100 - 500 | 2014 | $150,898,720 |
Freenome, Inc. provides clinical research services. The Company develops and creates screening, diagnosis, and treatment of age-associated clinical conditions. Freenome serves patients and the healthcare sector in the United States. | South San Francisco | CA | 200 - 1,000 | 2014 | $1,351,550,080 |
Automating Retail
Simbe Robotics builds automation solutions for the retail industry. Simbe’s first product, Tally, is the world’s first fully autonomous shelf auditing and analytics solution; one that provides retailers unprecedented visibility and ins | South San Francisco | CA | 20 - 50 | 2014 | $54,000,000 |
ORIC Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company discovers and develops novel therapies for the treatment of cancer diseases. ORIC Pharmaceuticals serves customers in the State of California. | South San Francisco | CA | 100 - 200 | 2014 | $408,000,000 |
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathw | South San Francisco | CA | 100 - 500 | 2014 | $239,100,000 |
TeraPore Technologies is a Cornell University spinout that develops and manufactures high performance filters for protein separations. | South San Francisco | CA | 20 - 50 | 2013 | $17,712,222 |
Alector, Inc. operates as a clinical stage biopharmaceutical company. The Company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders. Alector offers its services in the State of California. | South San Francisco | CA | 200 - 500 | 2013 | $269,500,000 |
Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease. | South San Francisco | CA | 5 - 10 | 2012 | $26,900,000 |
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. They aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HP | South San Francisco | CA | 10 - 50 | 2012 | $140,346,016 |
Claritas Rx is a digital health venture that brings clarity to the challenges of specialty biopharmaceutical products in the marketplace. In today’s highly complex specialty networks, our mission is to illuminate the patient experience beyond the clinical | South San Francisco | CA | 100 - 500 | 2011 | |
Calithera Biosciences is a development-stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. They are applying Their scientific expertise to build a pipeline of unique anti- canc | South San Francisco | CA | 10 - 50 | 2010 | $341,400,000 |
Principia Biopharma Inc. operates as a clinical stage biopharmaceutical company. The Company offers reversible covalent small molecule drugs for the treatment of cancers. Principia Biopharma serves patients in the United States. | South San Francisco | CA | 50 - 200 | 2008 | $337,799,968 |
Neurona Therapeutics Inc. operates as a clinical-stage biotherapeutics company. The Company focuses on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system. Neurona Therapeutics serves customers in the | South San Francisco | CA | 20 - 100 | 2008 | $320,313,920 |
Amunix Inc. is a pharmaceutical company. The Company focuses on therapeutic drugs which offer an alternative to antibodies and small molecules. Amunix also concentrates on protein design and the discovery research process. | South San Francisco | CA | 20 - 100 | 2006 | $190,000,000 |
Veracyte, Inc. develops molecular tests for oncology. The Company offers molecular cytology and tests for the diagnostic accuracy of cytology samples. Veracyte provides its products and services to healthcare and molecular diagnostic companies in the Unite | South San Francisco | CA | 500 - 1,000 | 2006 | $1,098,150,016 |
Valgenesis, Inc. designs and develops healthcare software. The Company offers equipment validation, risk management, content management, test case execution, business process modeling, integration, and support services. | South San Francisco | CA | 200 - 1,000 | 2005 | $24,400,000 |
Sutro Biopharma, Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Sutro Biopharma serves the pharmaceutical industries throughout the Uni | South San Francisco | CA | 200 - 500 | 2003 | $636,604,992 |
Nodality develops biologically-informed clinical treatments for patients with cancer and autoimmune diseases. | South San Francisco | CA | 50 - 200 | 2003 | $62,040,000 |
Diadexus is a post-genomics company focused on translating raw genomics data into novel diagnostic and therapeutic products. The company develops these diagnostic and therapeutic products for improved detection, classification and prognosis of diseases. | South San Francisco | CA | 20 - 100 | 1997 | $171,200,000 |
Catalyst Biosciences, Inc. operates as a biopharmaceutical company. The Company develops novel medicines to address hematology indications, as well as deals in treatment of hemophilia and surgical bleeding. Catalyst Biosciences serves patients in the Unit | South San Francisco | CA | 50 - 100 | 1997 | $301,314,496 |
Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotec | South San Francisco | CA | 10,000 - 50,000 | 1976 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.